Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,206 | 1 | 44.9% |
| Consulting Fee | $1,000 | 1 | 37.2% |
| Food and Beverage | $404.61 | 6 | 15.0% |
| Education | $77.95 | 2 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Roche Products Limited | $1,434 | 2 | $0 (2019) |
| IMPEL PHARMACEUTICALS INC. | $1,000 | 1 | $0 (2022) |
| EMD Serono, Inc. | $176.61 | 5 | $0 (2020) |
| Genentech, Inc. | $77.95 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,000 | 1 | IMPEL PHARMACEUTICALS INC. ($1,000) |
| 2020 | $45.06 | 2 | EMD Serono, Inc. ($45.06) |
| 2019 | $1,540 | 5 | Roche Products Limited ($1,434) |
| 2018 | $57.17 | 1 | EMD Serono, Inc. ($57.17) |
| 2017 | $46.26 | 1 | EMD Serono, Inc. ($46.26) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/14/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Migraine | ||||||
| 06/11/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Neurology | ||||||
| 02/12/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Neurology | ||||||
| 06/12/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Education | In-kind items and services | $39.95 | General |
| Category: None | ||||||
| 06/07/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Neurology | ||||||
| 02/28/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Education | In-kind items and services | $38.00 | General |
| Category: None | ||||||
| 02/06/2019 | Roche Products Limited | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $1,206.21 | General |
| Category: None | ||||||
| 02/06/2019 | Roche Products Limited | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $228.00 | General |
| Category: None | ||||||
| 05/30/2018 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | In-kind items and services | $57.17 | General |
| Category: Neurology | ||||||
| 08/05/2017 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | Cash or cash equivalent | $46.26 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 78 | 105 | $36,526 | $6,634 |
| 2022 | 1 | 64 | 76 | $23,449 | $5,658 |
| 2021 | 1 | 48 | 70 | $21,168 | $6,507 |
| 2020 | 2 | 67 | 82 | $26,183 | $5,764 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 65 | 90 | $32,544 | $5,799 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 15 | $3,982 | $835.76 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 47 | 59 | $18,094 | $3,798 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $5,355 | $1,860 | 34.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 48 | 70 | $21,168 | $6,507 | 30.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 38 | 47 | $16,889 | $3,810 | 22.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 35 | $9,294 | $1,954 | 21.0% |
About Dr. Gary Stobbe, MD
Dr. Gary Stobbe, MD is a Neurology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528054616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Stobbe, MD has received a total of $2,689 in payments from pharmaceutical and medical device companies, with $1,000 received in 2022. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($1,206).
As a Medicare-enrolled provider, Stobbe has provided services to 257 Medicare beneficiaries, totaling 333 services with total Medicare billing of $24,563. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Seattle, WA
- Active Since 09/23/2005
- Last Updated 04/27/2009
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1528054616
Products in Payments
- Non-Covered Product (Drug) $1,512
- Trudhesa (Drug) $1,000
- Rebif (Biological) $103.43
- Mavenclad (Drug) $45.06
- Mavenclad (Biological) $28.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Seattle
Dr. Pavle Repovic, Md, Phd, MD, PHD
Neurology — Payments: $1.2M
Nathaniel Watson, Md, MD
Neurology — Payments: $352,101
Mariko Kita, Md, MD
Neurology — Payments: $243,050
Kyra Becker
Neurology — Payments: $239,174
Christyn Edmundson, Md, MD
Neurology — Payments: $226,530
Pravin Khemani, Md, MD
Neurology — Payments: $199,884